Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2006-05-01 | Mr. Stuppin was elected Chairman of the Board in May 1995. ... The Compensation Committee of the Board of Directors currently consists of John B. Stuppin, Michael Kasper and Philip Wolfson. No director serving on the Compensation Committee is or has been an officer or employee of the Company or any of the Companys subsidiaries. ... The Audit Committee of the Board of Directors, which currently consists of Messrs. Casentini (Chairman), Stuppin and Kasper, held five meetings in 2005. |
| 2007-04-30 | Mr. Stuppin was elected Chairman of the Board in May 1995. Since September 1987, Mr. Stuppin has served in various executive capacities with Neurobiological Technologies, Inc. ("NTI"), a biomedical development company he co-founded, and he currently serves as a director of NTI. Mr. Stuppin also has been an investment banker and a venture capitalist, with over 25 years of experience in the founding and management of companies active in emerging technologies. The Audit and Finance Committee of the Board of Directors, which currently consists of Messrs. Cassentini (Chairman), Stuppin and Kasper, held four meetings in 2006. The following table summarizes the compensation paid to non-employee directors during 2006: John B. Stuppin Fees Earned in Cash 40,000, Stock Awards —, Option Awards 44,885, Total 84,885. |
Data sourced from SEC filings. Last updated: 2026-02-03